At Discovery Biotech, our team consists of leading scientists and clinical experts who integrate a wealth of knowledge with a proven track record of innovative problem-solving in translational medicine. This deep and broad scientific acumen enables us to identify and develop groundbreaking therapies that address the complex mechanisms behind resistance to cancer treatment.

Resistance to cancer treatment develops when cancer cells evolve to evade the effects of initially effective therapies through genetic mutations, alterations in drug processing, or changes in the microenvironment of the tumor. This resistance can render treatments ineffective and lead to disease progression. Currently, there are no definitive therapies to completely prevent or reverse this resistance, making it a major challenge in cancer treatment.

Following 15 years of diligent research and extensive laboratory testing, our initial four products have been specifically designed to combat cancer therapy resistance. These treatments currently stand as the only effective solutions for addressing cancer therapy resistance, as evidenced by rigorous laboratory testing.